Cryptic determinants and promiscuous sequences on human acetylcholine receptor

HLA-dependent dichotomy in T-cell function

Raghavan Pillai Raju, Eric Marietta, Javier Vinasco, Bianca M. Conti-Fine, Anthony J. Infante, Chella S. David

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Experimental autoimmune myasthenia gravis can be induced in some strains of mice and rats by immunizing with acetylcholine receptor. Also, epidemiologic studies demonstrate an MHC linkage of myasthenia gravis in the man. In order to obtain direct experimental evidence for the influence of the genes of the MHC complex in the development of myasthenia gravis, we used mice transgenic to individual HLA molecules. We observed an increased susceptibility to the disease in HLA DQ8 transgenic mice compared to HLA DQ6 transgenic mice (J. Immunol. 160:4169; 1998). These mice lacked endogenous mouse class II molecules. In the present study we mapped the cryptic and dominant sequences on the extra cellular region of human acetylcholine receptor. Although some epitopes (e.g., α11-30, α141-160, α171-190) were common between DQ8 and DQ6 transgenic mice, several others were disparately recognized. We also found a functional dichotomy in T cells from mice differing by one MHC molecule (HLA DQ8 or DQ6) when primed by sequences immunodominant in DQ8 and DQ6 tg mice. Differential disease manifestation in the two different HLA transgenic mice could be explained not only by differential recognition of peptides by these antigen presenting molecules, but also by the difference in the functional profile of T cells generated when primed by promiscuous sequence regions.

Original languageEnglish (US)
Pages (from-to)237-247
Number of pages11
JournalHuman Immunology
Volume63
Issue number4
DOIs
StatePublished - Apr 23 2002

Fingerprint

Cholinergic Receptors
Transgenic Mice
T-Lymphocytes
Myasthenia Gravis
Autoimmune Experimental Myasthenia Gravis
Disease Susceptibility
Epidemiologic Studies
Epitopes
Antigens
Peptides
Genes
HLA-DQ6 antigen
HLA-DQ8 antigen

Keywords

  • Antigen presentation
  • Autoimmunity
  • Cytokines
  • Myasthenia gravis
  • Transgenic/knockout

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Cryptic determinants and promiscuous sequences on human acetylcholine receptor : HLA-dependent dichotomy in T-cell function. / Raju, Raghavan Pillai; Marietta, Eric; Vinasco, Javier; Conti-Fine, Bianca M.; Infante, Anthony J.; David, Chella S.

In: Human Immunology, Vol. 63, No. 4, 23.04.2002, p. 237-247.

Research output: Contribution to journalArticle

Raju, Raghavan Pillai ; Marietta, Eric ; Vinasco, Javier ; Conti-Fine, Bianca M. ; Infante, Anthony J. ; David, Chella S. / Cryptic determinants and promiscuous sequences on human acetylcholine receptor : HLA-dependent dichotomy in T-cell function. In: Human Immunology. 2002 ; Vol. 63, No. 4. pp. 237-247.
@article{0d59882338b14cde8805908c93e82881,
title = "Cryptic determinants and promiscuous sequences on human acetylcholine receptor: HLA-dependent dichotomy in T-cell function",
abstract = "Experimental autoimmune myasthenia gravis can be induced in some strains of mice and rats by immunizing with acetylcholine receptor. Also, epidemiologic studies demonstrate an MHC linkage of myasthenia gravis in the man. In order to obtain direct experimental evidence for the influence of the genes of the MHC complex in the development of myasthenia gravis, we used mice transgenic to individual HLA molecules. We observed an increased susceptibility to the disease in HLA DQ8 transgenic mice compared to HLA DQ6 transgenic mice (J. Immunol. 160:4169; 1998). These mice lacked endogenous mouse class II molecules. In the present study we mapped the cryptic and dominant sequences on the extra cellular region of human acetylcholine receptor. Although some epitopes (e.g., α11-30, α141-160, α171-190) were common between DQ8 and DQ6 transgenic mice, several others were disparately recognized. We also found a functional dichotomy in T cells from mice differing by one MHC molecule (HLA DQ8 or DQ6) when primed by sequences immunodominant in DQ8 and DQ6 tg mice. Differential disease manifestation in the two different HLA transgenic mice could be explained not only by differential recognition of peptides by these antigen presenting molecules, but also by the difference in the functional profile of T cells generated when primed by promiscuous sequence regions.",
keywords = "Antigen presentation, Autoimmunity, Cytokines, Myasthenia gravis, Transgenic/knockout",
author = "Raju, {Raghavan Pillai} and Eric Marietta and Javier Vinasco and Conti-Fine, {Bianca M.} and Infante, {Anthony J.} and David, {Chella S.}",
year = "2002",
month = "4",
day = "23",
doi = "10.1016/S0198-8859(02)00362-2",
language = "English (US)",
volume = "63",
pages = "237--247",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Cryptic determinants and promiscuous sequences on human acetylcholine receptor

T2 - HLA-dependent dichotomy in T-cell function

AU - Raju, Raghavan Pillai

AU - Marietta, Eric

AU - Vinasco, Javier

AU - Conti-Fine, Bianca M.

AU - Infante, Anthony J.

AU - David, Chella S.

PY - 2002/4/23

Y1 - 2002/4/23

N2 - Experimental autoimmune myasthenia gravis can be induced in some strains of mice and rats by immunizing with acetylcholine receptor. Also, epidemiologic studies demonstrate an MHC linkage of myasthenia gravis in the man. In order to obtain direct experimental evidence for the influence of the genes of the MHC complex in the development of myasthenia gravis, we used mice transgenic to individual HLA molecules. We observed an increased susceptibility to the disease in HLA DQ8 transgenic mice compared to HLA DQ6 transgenic mice (J. Immunol. 160:4169; 1998). These mice lacked endogenous mouse class II molecules. In the present study we mapped the cryptic and dominant sequences on the extra cellular region of human acetylcholine receptor. Although some epitopes (e.g., α11-30, α141-160, α171-190) were common between DQ8 and DQ6 transgenic mice, several others were disparately recognized. We also found a functional dichotomy in T cells from mice differing by one MHC molecule (HLA DQ8 or DQ6) when primed by sequences immunodominant in DQ8 and DQ6 tg mice. Differential disease manifestation in the two different HLA transgenic mice could be explained not only by differential recognition of peptides by these antigen presenting molecules, but also by the difference in the functional profile of T cells generated when primed by promiscuous sequence regions.

AB - Experimental autoimmune myasthenia gravis can be induced in some strains of mice and rats by immunizing with acetylcholine receptor. Also, epidemiologic studies demonstrate an MHC linkage of myasthenia gravis in the man. In order to obtain direct experimental evidence for the influence of the genes of the MHC complex in the development of myasthenia gravis, we used mice transgenic to individual HLA molecules. We observed an increased susceptibility to the disease in HLA DQ8 transgenic mice compared to HLA DQ6 transgenic mice (J. Immunol. 160:4169; 1998). These mice lacked endogenous mouse class II molecules. In the present study we mapped the cryptic and dominant sequences on the extra cellular region of human acetylcholine receptor. Although some epitopes (e.g., α11-30, α141-160, α171-190) were common between DQ8 and DQ6 transgenic mice, several others were disparately recognized. We also found a functional dichotomy in T cells from mice differing by one MHC molecule (HLA DQ8 or DQ6) when primed by sequences immunodominant in DQ8 and DQ6 tg mice. Differential disease manifestation in the two different HLA transgenic mice could be explained not only by differential recognition of peptides by these antigen presenting molecules, but also by the difference in the functional profile of T cells generated when primed by promiscuous sequence regions.

KW - Antigen presentation

KW - Autoimmunity

KW - Cytokines

KW - Myasthenia gravis

KW - Transgenic/knockout

UR - http://www.scopus.com/inward/record.url?scp=0036229420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036229420&partnerID=8YFLogxK

U2 - 10.1016/S0198-8859(02)00362-2

DO - 10.1016/S0198-8859(02)00362-2

M3 - Article

VL - 63

SP - 237

EP - 247

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 4

ER -